Big Tech giants like Google, Amazon, Microsoft, Apple and IBM have long dominated sectors like consumer technology, cloud computing and artificial intelligence. These companies have also significantly expanded their footprint in the healthcare industry in recent years. With their vast financial resources and capabilities in areas such as data analytics, AI, cloud infrastructure and consumer technologies, Big Tech sees healthcare and life sciences as a major opportunity area.
Several acquisitions and initiatives over the past decade indicate Big Tech’s growing interest in healthcare. For example, Google acquired Fitbit in 2021 for $2.1 billion to enter the wearables space and they have bought and created several companies (e.g. Alphabet, DeepMind, Isomorphic Labs) that plan or create drugs with AI and this is only a small example of some of where they are playing in healthcare. Amazon acquired PillPack in 2018 for $753 million to build its pharmacy business and then One Medical the Telehealth company. The next big move from them to close the pharma supply chain would be to purchase a generics/biosimilar company. Whether they do remains to be seen. IBM also acquired many companies (e.g. Explorys, Phytel, Merge Healthcare and others) to bolster its AI and analytics capabilities for healthcare.
Beyond acquisitions, companies are also partnering with providers to apply their technologies. For instance, Microsoft has partnered with the VA to implement AI tools to improve veteran care. As patient data grows exponentially, Big Tech firms believe they are well-positioned to leverage analytics and AI to help modernize the healthcare system and improve outcomes. Their end goal is to establish an omnipresent role across the healthcare ecosystem from drug discovery to point-of-care delivery.
If we look at some of the big moves throughout the value chain we have
R&D: Google’s Alphabet and Microsoft are both collecting and mining data to identify biomarkers and drug targets.
Clinical Development: Apple, Google’s Alphabet and Microsoft are both in the area with patient recruitment and monitoring, Digital biomarkers and Digital twins.
Supply Chain: Amazon are working in Drug demand and supply planning and Supply chain visibility
Commercialization: Amazon and Microsoft are both working in physician decision support, digital pharmacies and HCP/clinics/virtual care
Monitoring and Health Records: Apple, Amazon, Google’s Alphabet, Microsoft are all working in this space with medication adherence, remote patient monitoring, HCP and patient data solutions and workflow solutions.
Venture funding for digital health startups reached $14.1 billion in 2023, up from $12.9 billion in 2022 according to Rock Health. This indicates continued strong investor interest in emerging healthcare technologies.
- Telehealth utilization remained elevated compared to pre-pandemic levels, with nearly a quarter of Americans using virtual care in 2023. However, growth slowed from the explosive rise seen during the pandemic. Permanent regulatory and reimbursement changes will be important to sustain virtual care moving forward.
- Investment in AI for healthcare grew substantially. Companies developing clinical decision support tools, predictive analytics, and other AI-powered solutions raised billions from investors in 2023. Use of AI also expanded in areas like drug discovery and clinical research.
- Digital therapeutics had a breakthrough year. The FDA authorized numerous prescription digital treatments for conditions like insomnia, smoking cessation, and ADHD. Reimbursement remains a challenge but progress was made with some payers covering certain DTx products.
- Wearables and remote patient monitoring expanded their role in healthcare. Continuous monitoring of vital signs, physical activity, and other health data helped manage chronic conditions and assisted seniors and high-risk patients. Integration with EHRs remains a focus.
- Health IT consolidation accelerated as large players looked to expand their offerings. This included several multi-billion dollar acquisitions of leading digital health companies. Interoperability and synergies were cited as motivations for these deals.
How Big Tech Companies are Leveraging AI and Data Analytics to Advance Healthcare
Big Tech firms have been aggressively investing in artificial intelligence and machine learning to tackle some of healthcare’s most pressing challenges. With their vast troves of patient data and computing power, companies like Google, Amazon and Microsoft are developing AI tools aimed at improving clinical decision-making, diagnostics, drug discovery and more.
One area that has seen significant progress very early on is medical imaging analysis. Radiology is a field that lends itself well to AI due to the large volumes of visual data. Google Health has trained AI models on hundreds of thousands of medical images to help detect diseases like diabetic retinopathy, pneumonia and breast cancer. But they are not alone, many AI companies are playing in this radiology space with great success. The algorithms in this space for diagnostics have shown accuracy exceeding human experts in most cases. Similarly, Microsoft has partnered with healthcare providers to apply AI to CT scans and MRIs and help improve the detection of conditions like cancers, infections and acute injuries. The models can rapidly analyze large imaging archives, flag anomalies and prioritize cases that require immediate clinical review.
Moving beyond imaging, Big tech are applying AI to other areas of healthcare. Amazon has developed AI tools to analyze free-text clinical notes in electronic health records (EHRs) and uncover insights. By processing vast amounts of unstructured data, their models can predict patient deterioration, identify high-risk cohorts for interventions and assist providers with clinical documentation. Google has trained natural language processing models on millions of de-identified patient records and medical literature to answer clinical questions at the point of care. Their AI system is being used by several major health systems to supplement clinician knowledge and reduce diagnostic errors.
When it comes to population health and public health, AI shows promise in disease surveillance and outbreak prediction. By tracking trends in medical claims, search queries and social media posts, AI systems can potentially provide early warnings of disease spread and resource allocation. During the COVID-19 pandemic, Amazon worked with the US National Institutes of Health (NIH) to analyze COVID-19 research papers, clinical trials data and other information sources using AI. Their models helped NIH scientists accelerate the discovery of treatments and vaccines. Microsoft has partnered with the US Centers for Disease Control and Prevention (CDC) to develop AI-based epidemiological forecasting tools and predictive analytics dashboards.
In terms of numbers, tech giants are now handling exabytes worth of healthcare data. For example, Google processes over 150 billion medical images, notes and other unstructured data in their AI/ML healthcare models each year. Amazon Web Services (AWS) stores and analyzes over 100 petabytes of genomic data in the cloud for researchers. Microsoft’s healthcare cloud annually handles over 1 billion patient records, 30 billion lab results and 1 trillion healthcare conversations. These massive datasets fuel the development of AI at an unprecedented scale and speed, allowing for new insights and applications to emerge rapidly.
While there are clear benefits to leveraging AI at such a scope, challenges around data governance, privacy, security, ethics, regulatory compliance and clinical validation still need to be addressed carefully. As more lives depend on these systems, ensuring their safe, equitable and transparent use will be paramount moving forward.
Consumer Healthcare Tools and Services
Big Tech firms have made significant strides in developing direct-to-consumer digital health products focused on personal wellness, prevention and care management. By building intuitive mobile apps and wearable devices, companies are empowering consumers to proactively monitor their health metrics outside of traditional clinical settings.
Fitness trackers remain one of the most popular categories. In 2023, over 150 million wearable devices were shipped globally according to IDC, with the top players being Apple, Samsung and Fitbit (owned by Google). These devices continuously track steps, heart rate, sleep and other biometrics to motivate healthy behaviours.
For example, the Apple Watch Series 8 has tools for irregular heart rhythm notifications, ECG readings and fall detection. Fitbit also added new features like blood glucose tracking and advanced sleep tools.
Health and wellness apps have seen tremendous growth as well. In 2023, over 325,000 mobile health apps were available on iOS and Android stores as per Research2Guidance. Popular offerings include those from Google like Fit, Apple like Health and Samsung like Health Monitor. These apps aggregate data from various devices and services to provide a unified view of metrics. They also offer guided programs for conditions like diabetes, hypertension, mental wellness and more. For instance, the Apple Health app saw over 100 million monthly active users in 2023.
Telehealth has emerged as a major segment with the pandemic accelerating virtual care adoption. Companies like Amazon Care, Microsoft HealthCare and Google’s Televicare offer multichannel services including video, chat and asynchronous care. They employ AI for triage, diagnosis and treatment monitoring. In 2023, over 50 million Americans used telehealth according to Rock Health, with virtual-first clinics gaining traction. For example, Amazon Care expanded nationally and handled over 5 million telehealth visits in 2023.
Overall, consumer acceptance of these tools has been strong. A 2023 Accenture survey found that over 70% of Americans now use some form of digital health technology for preventive care and chronic condition management. As data aggregation and AI-powered insights improve, Big Tech’s direct-to-consumer offerings have the potential to transform the relationship between individuals and their health in meaningful ways.
Partnering with Healthcare Providers
Big Tech companies have been actively partnering with hospitals, health systems, insurers and life sciences firms to apply their technologies within core clinical and operational areas. By integrating solutions into existing electronic health record (EHR) systems and care processes, these collaborations aim to streamline workflows, improve outcomes and reduce costs.
One of the largest deals saw Microsoft acquire Nuance Communications in 2022 for $19.7 billion. Nuance provides clinical speech recognition and AI solutions that are embedded in over half of U.S. hospital EHRs. This strengthened Microsoft’s position in the healthcare cloud and expanded its AI capabilities for clinical documentation, coding and imaging analysis use cases.
Google Cloud has also pursued major EHR partnerships. In 2023, they announced an agreement with Epic to jointly develop AI and data analytics tools integrated within Epic’s records system used by over 250 million patients. This will allow the application of Google’s models for tasks like predictive care management and automated clinical notes.
Amazon Web Services (AWS) maintains a strong focus on population health and life sciences through strategic alliances. They formed a research collaboration with Duke Health in 2023 to use AWS AI services and real-world data to accelerate clinical trials and new treatment discoveries. With UnitedHealth Group, AWS is building cloud-based tools for risk adjustment, claims processing and care management.
Apple has made inroads within ambulatory settings. Their Health Records app, which securely accesses medical data from EHRs, expanded to over 500 hospitals in 2023 including Johns Hopkins and Cedars-Sinai. Apple also works with health insurers to offer members financial incentives for participating in wellness programs and sharing data with doctors through the Health app.
By embedding solutions into clinical workflows, these partnerships aim to streamline care delivery while generating insights to advance medicine. If data governance and security best practices are followed, they have the potential to significantly improve patient and provider experiences.
Health Data Management and Interoperability
The ability to securely share and integrate health information across different systems, providers and stakeholders has immense potential for improving care coordination and patient outcomes. However, fragmented data silos have been a long-standing challenge in healthcare. According to a 2023 report by the Office of the National Coordinator for Health Information Technology, lack of interoperability costs the U.S. economy over $2 trillion annually due to redundant tests, medical errors and inefficient workflows.
Access to comprehensive longitudinal data on individuals is key for powering advanced analytics that can help prevent illness before it starts. Complete medical records with social, lifestyle and genetic factors would allow for more holistic risk prediction models and personalized care plans. This is an area where Big Tech’s expertise in data engineering, cloud infrastructure and AI can significantly aid the healthcare sector’s ongoing digital transformation efforts.
Big Tech’s role in developing health data standards and Infrastructure
All major Tech companies have been actively involved in developing common data standards and specifications to help break down silos and enable seamless exchange of information across the fragmented healthcare system. For instance, Microsoft leads the development of one of the most widely used interoperability frameworks called Fast Healthcare Interoperability Resources (FHIR). Google also contributes to the FHIR standard and offers services compatible with it on their Google Cloud Platform.
In addition, Big Tech is building large-scale health data networks and repositories. Amazon’s healthcare business AWS maintains one of the world’s largest clinical trial platforms called Clinical Study Data Manager which brings together data from thousands of studies. Similarly, IBM’s Watson Health is working with providers to create centralized data lakes and analytics platforms adhering to common standards. If properly governed, these centralized databases have the potential to accelerate the discovery of new treatments by enabling researchers to integrate diverse datasets for machine learning.
As data volumes and computing needs continue ballooning, cloud infrastructure provided by Tech giants will remain indispensable for healthcare. Their ongoing work to develop open interoperability standards and federated data networks can help unleash data’s power for improving population health if implemented responsibly with strong privacy and consent controls.
Wearable Technology and Remote Monitoring
The global wearable medical device market has experienced rapid growth in recent years and is projected to be worth over $30 billion by 2027 according to Allied Market Research. Driven by rising demand for wireless health monitoring solutions and greater consumer interest in proactive health tracking, wearable technology adoption is becoming increasingly mainstream. In 2023, over 150 million wearable devices were shipped worldwide with healthcare and fitness-related applications being a major use case as reported by International Data Corporation.
Leading this expansion are the major tech companies that have invested heavily in developing sophisticated wearables for medical and clinical purposes. For example, Apple dominates over 50% of the market with its Apple Watch series featuring tools for ECG readings, fall detection, irregular rhythm notifications and integration with various health apps. Google’s Fitbit portfolio acquired in 2021 provides advanced tracking of metrics like heart rate, SpO2, sleep stages and stress levels. Meanwhile, Samsung has partnered with the FDA to expand its Galaxy Watch capabilities to remotely monitor conditions like hypertension and diabetes. Data from these devices is also feeding into the development of AI-powered insights and virtual care services by respective companies. Overall, Big Tech’s R&D is at the forefront of driving wearable technology deeper into healthcare delivery and revolutionizing preventive medicine through continuous remote patient monitoring at scale.
Challenges and Future Outlook
While Big Tech partnerships and initiatives offer promising opportunities to advance healthcare through technology, major challenges still exist around data governance that need to be addressed carefully. As these companies gain deeper access to sensitive patient information, concerns persist regarding privacy, security, ethics and the potential for data misuse or breach. Ensuring strict access controls, transparency around use cases and giving individuals ownership over their data will be critical to building trust.
Regulatory compliance is another hurdle, as healthcare remains highly regulated with complex laws and standards around research, clinical trials and market access that non-traditional tech firms are still learning to navigate. Close oversight will be required to verify their solutions meet all safety, efficacy and quality requirements before widespread adoption. There are also debates around tech giants’ growing influence potentially crowding out startups and stifling innovation if left unchecked.
Looking ahead, as data aggregation and AI capabilities continue progressing rapidly, Big Tech’s role in virtually every facet of healthcare delivery is poised to significantly expand. More advanced digital tools for remote patient monitoring, virtual visits, precision diagnostics, drug discovery and personalized treatment recommendations will likely become mainstream. Their consumer-facing platforms also have the potential to empower individuals to proactively manage their well-being.
Healthcare systems worldwide are projected to face mounting pressures around rising costs, provider shortages and growing chronic disease burden. If privacy safeguards are established, Big Tech’s population health-oriented approach combining vast amounts of medical data with next-gen analytics could help address these challenges at an unprecedented scale through more predictive, preventive and participatory models of care. However, specialized regulation may still be required to ensure these new models augment rather than replace traditional medical expertise and human touchpoints which remain central to high-quality care.
Overall, while uncertainties exist, most industry experts forecast Big Tech’s healthcare footprint will continue multiplying rapidly in the coming decade based on current momentum. Their end-goal appears to be establishing an omnipresent yet behind-the-scenes role across the entire health ecosystem as a driving force to modernize dated systems and workflows through innovative applications of technology.
Conclusion
Big Tech companies have significantly expanded their role in healthcare through strategic investments and partnerships that leverage their capabilities in cloud, AI, data analytics and consumer technologies. As discussed, initiatives across areas such as medical imaging analysis, electronic health records, telehealth and remote patient monitoring indicate their growing influence. Managing health data at scale and developing interoperability standards are also important contributions that can help address long-standing challenges around information sharing between providers.
Looking ahead, as digital tools for predictive and participatory care models mature, Big Tech is poised to reshape how healthcare is delivered. While this brings opportunities to modernize outdated systems and empower individuals, it also raises concerns around privacy, market dominance if unchecked, and the potential to crowd out startups. Responsible leadership and oversight will be needed from all stakeholders including regulators to ensure technology augments rather than replaces human expertise and relationships central to quality care. Overall, through open collaboration and prioritizing user trust, there is potential for Big Tech to play a driving role in building more equitable, preventive and affordable healthcare systems worldwide.
Found this article interesting?
P.S. Here are 5 ways we can help you accelerate your Pharma AI results:
1. Follow Dr Andrée Bates LinkedIn Profile Now
Revolutionize your team’s AI solution vendor choice process and unlock unparalleled efficiency and save millions on poor AI vendor choices that are not meeting your needs! Stop wasting precious time sifting through countless vendors and gain instant access to a curated list of top-tier companies, expertly vetted by leading pharma AI experts.
Every year, we rigorously interview thousands of AI companies that tackle pharma challenges head-on. Our comprehensive evaluations cover whether the solution delivers what is needed, their client results, their AI sophistication, cost-benefit ratio, demos, and more. We provide an exclusive, dynamic database, updated weekly, brimming with the best AI vendors for every business unit and challenge. Plus, our cutting-edge AI technology makes searching it by business unit, challenge, vendors or demo videos and information a breeze.
- Discover vendors delivering out-of-the-box AI solutions tailored to your needs.
- Identify the best of the best effortlessly.
- Anticipate results with confidence.
Transform your AI strategy with our expertly curated vendors that walk the talk, and stay ahead in the fast-paced world of pharma AI!
Get on the wait list to access this today. Click here.
4. Take our FREE AI for Pharma Assessment
This assessment will score your current leveraging of AI against industry best practice benchmarks, and you’ll receive a report outlining what 4 key areas you can improve on to be successful in transforming your organization or business unit.
Plus receive a free link to our webinar ‘AI in Pharma: Don’t be Left Behind’. Link to assessment here
5. Learn more about AI in Pharma in your own time
We have created an in-depth on-demand training about AI specifically for pharma that translate it into easy understanding of AI and how to apply it in all the different pharma business units — Click here to find out more.